- Home
- LAC vs ABSI Comparison
LAC vs ABSI Comparison
Compare LAC & ABSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LAC | ABSI |
|---|---|---|
| Founded | 2023 | 2011 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Metal Mining | Biotechnology: Pharmaceutical Preparations |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 997.8M |
| IPO Year | 2023 | 2021 |
Fundamental Metrics
Financial Performance| Metric | LAC | ABSI |
|---|---|---|
| Price | $3.01 | $9.01 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 7 | 4 |
| Target Price | $6.14 | ★ $6.96 |
| AVG Volume (30 Days) | ★ 9.4M | 2.7M |
| Earning Date | 05-14-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 10.64 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $4,534,000.00 |
| Revenue This Year | N/A | $215.96 |
| Revenue Next Year | N/A | $319.10 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.67 | $2.24 |
| 52 Week High | $10.52 | $12.06 |
Technical Indicators
Market Signals| Indicator | LAC | ABSI |
|---|---|---|
| Relative Strength Index (RSI) | 40.15 | 48.24 |
| Support Level | $2.90 | $8.55 |
| Resistance Level | $3.58 | $10.03 |
| Average True Range (ATR) | 0.15 | 0.57 |
| MACD | 0.00 | -0.06 |
| Stochastic Oscillator | 5.15 | 16.22 |
Price Performance
Historical ComparisonAbout LAC Lithium Americas Corp.
Lithium Americas Corp is a Canadian-based resource and materials company focused on developing, building and operating lithium deposits and chemical processing facilities. The company also holds investments in Green Technology Metals Limited (GT1) and Ascend Elements, Inc. (Ascend Elements), and exploration properties in the U.S. and Canada. The company's flagship asset is Thacker Pass, a sedimentary-based lithium deposit located in the McDermitt Caldera in Humboldt County, in northern Nevada (Thacker Pass or the Project). The company operates in only one operating segment and one geographical segment.
About ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process. Its lead product candidate, ABS-201, is an anti-prolactin receptor (PRLR) antibody engineered with an extended half-life to support a patient-friendly dosing interval.